Analysts Set Masimo Corporation (NASDAQ:MASI) Target Price at $180.40

Masimo Corporation (NASDAQ:MASI) has been assigned an average rating of “Hold” from the nine research firms that are covering the firm, MarketBeat.com reports. Nine research analysts have rated the stock with a hold recommendation. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $180.40.

A number of equities analysts have recently commented on the company. BTIG Research downgraded Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th. Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Wells Fargo & Company upgraded Masimo to a “hold” rating in a research report on Wednesday, March 18th. Stifel Nicolaus set a $180.00 target price on shares of Masimo in a research report on Tuesday, February 17th. Finally, Wolfe Research cut Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of MASI. Global Retirement Partners LLC purchased a new position in shares of Masimo in the fourth quarter valued at $27,000. Aster Capital Management DIFC Ltd acquired a new position in Masimo during the 4th quarter valued at approximately $28,000. Los Angeles Capital Management LLC acquired a new stake in shares of Masimo in the fourth quarter valued at approximately $31,000. Rothschild Investment LLC raised its position in shares of Masimo by 12,950.0% during the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after buying an additional 259 shares in the last quarter. Finally, Torren Management LLC bought a new position in Masimo during the fourth quarter valued at about $35,000. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Price Performance

Shares of MASI opened at $179.95 on Wednesday. The stock has a 50 day moving average price of $178.75 and a 200 day moving average price of $161.14. The stock has a market capitalization of $9.42 billion, a price-to-earnings ratio of -17.07, a PEG ratio of 1.82 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.68. Masimo has a one year low of $125.94 and a one year high of $179.99.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.